Raymond James & Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,100
Closed -$30K 3657
2019
Q2
$30K Buy
+10,100
New +$811K ﹤0.01% 3538

Other funds holding INCY

Raymond James & Associates's INCY Position: Q3 2024 in Review

Raymond James & Associates reduced its Incyte (INCY) stake by 21% in Q3 2024, selling an estimated $464K and leaving 27,511 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Raymond James & Associates first reported a position in INCY in Q2 2013 and has held it in 42 quarters since. The position peaked at $21.1M in Q2 2019. 592 funds tracked by Wall St. Rank hold INCY as of Q3 2024.

  • Raymond James & Associates held 27,511 shares of Incyte worth $1.82M as of Q3 2024.
  • Raymond James & Associates sold 7,279 Incyte shares in Q3 2024, an estimated $464K.
  • Incyte made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2290 holding.
  • Raymond James & Associates first reported a position in Incyte in Q2 2013 and has held it in 42 quarters since.
  • Raymond James & Associates's Incyte position peaked at $21.1M in Q2 2019.
  • 592 funds tracked by Wall St. Rank held Incyte as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.